New York patients who are undergoing testing for potential skin cancer may be interested to learn that a deep learning convolutional neural network may be more accurate when detecting benign or malignant skin lesions than human professionals. The study to test this involved researchers from the U.S., France and Germany.
Doctors in New York could be misdiagnosing nearly 25 percent of all age-related macular degeneration cases, according to a study. The research was published in JAMA Ophthalmology.
New Yorkers may be concerned about the quality of care they will receive when they enter the hospital for surgery or other serious medical treatment. A spring 2018 safety report card issued by the Leapfrog Group noted that standards had improved at four hospitals in Central New York while safety grades had declined at four additional medical centers in the region. The report is issued twice a year and assigns letter grades– A, B, C, D and F — to hospital safety practices across the country.
An international team of researchers has identified a biomarker associated with interstitial cystitis, a painful bladder disease that demands constant urination. Through the process of DNA methylation analysis, researchers found biomarkers in the urine of people with IC that could improve the ability of physicians in New York to diagnose the disease accurately and early.
Mitochondria, which are found in all cells except red blood cells, provide a majority of the body’s energy. When mitochondria become diseased, therefore, they can affect almost any part of the body and cause a wide range of symptoms to arise. Patients in New York who suffer from a mitochondrial disease are probably aware that their conditions are difficult to diagnose.
